Commonwealth of Pennsylvania Prescription Monitoring Program
The Office of Attorney General is authorized by law under Title 28 Pa Code, Chapter 25, Subchapter A, Section 25.131 to collect data regarding the dispensation of Schedule II controlled substances by pharmacies in Pennsylvania.
This function is administered by the Bureau of Narcotics Investigation (BNI), which has both criminal investigative authority and regulatory compliance authority with regard to controlled substances under Pennsylvania's drug act, commonly referred to as "Act 64".
The Office of Attorney General contracts with a private vendor for the collection of this data from pharmacies in the state. That vendor utilizes the industry standard format for data collection as developed by the American Society for Automation in Pharmacy (ASAP), with several reporting options.
Pharmacies having technical questions regarding compliance with these reporting requirements are directed to:
Optimum Technology, Inc.
100 E. Campus View Blvd.
Columbus, OH 43235
Pharmacies having questions about legal issues regarding compliance with these reporting requirements can direct same to:
Senior Deputy Attorney General Lawrence Cherba
Health care practitioners can report cases of suspected drug diversion via email to: Drugdiversion@attorneygeneral.gov. Please include appropriate contact information, including callback number and address, including county.
Please note: Pennsylvania law requires only the reporting of Schedule II controlled substances. In addition, there is currently no legal provision for access to PMP data by non-law enforcement personnel.
Prescription Drug Abuse Education Programs are offered by the Attorney General's Education & Outreach Unit, including an original video production titled "Consequences" which targets information about prescription drug abuse to students. Organizations seeking speakers or other resources on the topic can contact the OAG Education & Outreach Unit at: email@example.com
The Office of Attorney General also supports "National Take Back Day" which is an effort to remove unused and unwanted prescription drugs from households and properly dispose of them. The U.S. Drug Enforcement Administration holds such efforts periodically. The effort allows citizens to drop off leftover pharmaceutical drugs at various locations across the state for proper collection and disposal. Details on the program, including dates and collection locations, can be found at: www.dea.gov